Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Clinical and Research Excellence Index

Close Icon

Events

Conferences 2020

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Tailor-made Pharma Solutions

Make better informed business decisions with customized pharmaceutical consulting and marketing services that give you the edge over your competition.

Tailor-made solutions

Use the expertise and experience of Pharma Intelligence to produce custom solutions that are actionable, flexible, and tailored to help you successfully navigate biopharma portfolio management, commercial optimization, and R&D strategy. Benefit from:

A customized approach – we develop solutions to fit your situation
Joint problem/opportunity definition
Proprietary data and complementary market research
The experience of 500+ industry experts
Collaborative problem solving
Fact-based decisions and actionable recommendations
Ownership of final decisions and action plans

Discover new business opportunities, reduce risks, and make better, faster decisions with tailor-made pharmaceutical solutions from Pharma Intelligence.

Scrip

Kancera Targets COVID-19 With Fractalkine Inhibitor

Sweden-based Kancera hopes to advance its investigative anti-inflammation drug in a Phase II trial to treat severe COVID-19 patients and then build its applications from there.

Topic Coronavirus Clinical Trials

View article
Scrip

Finance Watch: Atea Pharmaceuticals Raises $215m For COVID-19 Antiviral

Private Company Edition: Atea and Phlow receive big money for big COVID-19 problems – treatments and manufacturing capacity. Also, Cowen raises a $493m fund and antifungal developer Amplyx increases series C round to $90m, among other recent VC deals.

Topic Coronavirus Financing Innovation

View article
Skipta

Navigating The Crisis Insights into Physicians and Marketers' Needs

The challenges presented by COVID-19 are likely to lead to a busy and stressful period for physicians. Therefore, it is important more than ever before that pharma companies reach physicians on the channels they trust. Skipta Gather lets you conduct virtual sessions with physicians selected according to your criteria.

Topic Advertising, Marketing & Sales

View infographic
Skipta

The Imapct of Covid-19 on B2B Marketers

When circumstances make meeting in person an impossibility, Skipta Gather is there. Don’t miss out on reaching your target audience because travel is curtailed and meetings are cancelled. Use Skipta Gather to conduct virtual sessions with verified physicians and get the job done.

Topic Advertising, Marketing & Sales

View infographic
Skipta

Cutting through the digital clutter to reach your target audience

In combating ad blindness and ad-blocking, this whitepaper explains how thoughtful, relevant messages, aimed at carefully-segmented audiences, can be delivered through channels that audiences trust and engage with.

Topic Digital Health

View white paper
Skipta

Pharma Marketing 2020: Maximizing product launch success amid complex legislative change

Healthcare professionals are notoriously hard to reach with new product messaging. Skipta makes it easier. A social network for verified physicians, Skipta communities are segmented by area of expertise or disease state. Use Skipta to create custom, targeted campaigns to reach your audience when they’re most ready to engage.

Topic Market Access

View white paper
Scrip

China Still Leading Vaccines Race Despite Moderna Data, US 'Warp Speed' Plan?

The unveiling of US president Donald Trump’s 'Warp Speed’ plan to fast-track a coronavirus vaccine and the latest promising Phase I data from Moderna's candidate haven't seemed to swing China’s belief that it’s still leading the race.

Topic Coronavirus

View article
Scrip

Moderna’s Early Data Gives Big Boost For COVID-19 Vaccine Hopes

First eight volunteers produced antibodies which match or surpass those seen in patients who have recovered from COVID-19 – but big test awaits in Phase III.

Topic Coronavirus

View article
Awareness, Lead generation, Our products and audiences

Powering Pharma and Medtech To Make Effective Clinical Regulatory and Commercial Decisions

With deep Pharma industry and marketing expertise, we can help you to reach Pharma’s elusive decision makers with relevant high-impact and engaging content, so you can reach your business and revenue objectives.

Topic Market Intelligence

View infographic
Awareness, Lead generation

Top 5 Tips for Producing Successful Webinars

Get valuable tips to maximize your webinar success from Informa Pharma Intelligence when you download our infographic. Learn the proven tactics our pharma marketing experts employ when planning our own webinar events

Topic Advertising, Marketing & Sales

View infographic
Lead generation, Thought leadership

5 Top Tips For Generating Successful Content Marketing

From choosing the right audience to measuring campaign results, follow these 5 tips when planning your successful content marketing campaign.

Topic Advertising, Marketing & Sales

View infographic
Pharmaprojects

New Active Substances (NAS) Launched During 2019 Infographic

Don’t miss your view into the NAS that made an impact last year, your follow-up to the Pharma R&D Annual Review 2020 webinar.

Topic Clinical Trials Research & Development

View infographic
Pharmaprojects

Pharma R&D Annual Review 2020 Whitepaper - NAS Supplement

Recently, Pharma Intelligence brought you the Pharma R&D Annual Review 2020 Webinar, followed up with the NAS (New Active Substances) Infographic. We now invite you to go even deeper into pharma R&D successes for 2019 with your free copy of the NAS Supplement.

Topic Clinical Trials Research & Development

View white paper
HBW Insight

CBD News Round-Up: Australia Proposes OTC Pathway, First EU Novel Food Validation, COVID Boost For UK Firm

Australia looks at switching CBD as an OTC medicine, CBDepot becomes the first European firm with an EU Novel Food validation and the UK's Vitality CBD gets a boost from the global, coronavirus-driven wellness trend.

Topic Dietary Supplements Coronavirus

View article
HBW Insight

IFRA Chair Looks Forward To Post-COVID-19 ‘Revival Of Reason’

IFRA’s new chairman Hans Holger Gliewe says one possible positive outcome of the COVID-19 pandemic could be that consumers go on putting a premium on scientific expertise after months of reliance on health experts’ advice.

Topic Coronavirus Cosmetics

View article

Latest headlines

Pink Sheet

15 May 2020

Republicans Favor Regulatory ‘Leeway’ On Drug Use During Emergencies, Bright Hearing Shows

Link
Pink Sheet

15 May 2020

Ousted BARDA Director Bright Says Hydroxychloroquine EUA Distracted From Coronavirus Work

Link
Scrip

15 May 2020

New Drug Launches Worldwide Dipped In 2019

Link
Pink Sheet

15 May 2020

Can GSK Veteran Moncef Slaoui Get COVID-19 Vaccine Development To Warp Speed?

Link
Pink Sheet

15 May 2020

EU Court Clarifies Another SPC Conundrum

Link
Generics Bulletin

15 May 2020

Slayback’s Belrapzo Non-Infringement Judgement Is Upheld On Appeal

Link
Pink Sheet

15 May 2020

COVID-19 And The Future Of Rx Pricing Policy: An Interview With White House Advisor Grogan

Link
HBW Insight

15 May 2020

GNC’s Deadline To Refinance Or Restructure Delayed Until August

Link
Pink Sheet

15 May 2020

US FDA Makes Final Decision On 'Inordinate' Out-Of-State Compounding

Link
Medtech Insight

15 May 2020

FDA Issues Warning Letters To Breast Implant Makers Allergan And Ideal Implant

Link
Scrip

15 May 2020

Sweden’s Affibody Inks Inmagene China R&D Pact

Link
HBW Insight

15 May 2020

Federal Official Would Monitor 'Price Gouging’ Under Latest US House Pandemic Relief Bill

Link
Scrip

15 May 2020

Hetero Head On Remdesivir Partnering, Royalty Model

Link
Medtech Insight

15 May 2020

US Patent Office Creates Accelerated Path For COVID-19 Products

Link
HBW Insight

15 May 2020

California Bill Advances To Ban Cosmetic Ingredients Prohibited In EU, With PCPC’s Backing

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Tailor-made Pharma Solutions

Tailor-made solutions

Pharma Intelligence latest insights

Kancera Targets COVID-19 With Fractalkine Inhibitor

Finance Watch: Atea Pharmaceuticals Raises $215m For COVID-19 Antiviral

Navigating The Crisis Insights into Physicians and Marketers' Needs

The Imapct of Covid-19 on B2B Marketers

Cutting through the digital clutter to reach your target audience

Pharma Marketing 2020: Maximizing product launch success amid complex legislative change

China Still Leading Vaccines Race Despite Moderna Data, US 'Warp Speed' Plan?

Moderna’s Early Data Gives Big Boost For COVID-19 Vaccine Hopes

Powering Pharma and Medtech To Make Effective Clinical Regulatory and Commercial Decisions

Top 5 Tips for Producing Successful Webinars

5 Top Tips For Generating Successful Content Marketing

New Active Substances (NAS) Launched During 2019 Infographic

Pharma R&D Annual Review 2020 Whitepaper - NAS Supplement

CBD News Round-Up: Australia Proposes OTC Pathway, First EU Novel Food Validation, COVID Boost For UK Firm

IFRA Chair Looks Forward To Post-COVID-19 ‘Revival Of Reason’

Latest headlines

Republicans Favor Regulatory ‘Leeway’ On Drug Use During Emergencies, Bright Hearing Shows

Ousted BARDA Director Bright Says Hydroxychloroquine EUA Distracted From Coronavirus Work

New Drug Launches Worldwide Dipped In 2019

Can GSK Veteran Moncef Slaoui Get COVID-19 Vaccine Development To Warp Speed?

EU Court Clarifies Another SPC Conundrum

Slayback’s Belrapzo Non-Infringement Judgement Is Upheld On Appeal

COVID-19 And The Future Of Rx Pricing Policy: An Interview With White House Advisor Grogan

GNC’s Deadline To Refinance Or Restructure Delayed Until August

US FDA Makes Final Decision On 'Inordinate' Out-Of-State Compounding

FDA Issues Warning Letters To Breast Implant Makers Allergan And Ideal Implant

Sweden’s Affibody Inks Inmagene China R&D Pact

Federal Official Would Monitor 'Price Gouging’ Under Latest US House Pandemic Relief Bill

Hetero Head On Remdesivir Partnering, Royalty Model

US Patent Office Creates Accelerated Path For COVID-19 Products

California Bill Advances To Ban Cosmetic Ingredients Prohibited In EU, With PCPC’s Backing

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store